Close Menu

Things are heating up in the blogosphere between developers of HMMer, the freely available popular sequence analysis tool originally written by Sean Eddy of Janelia Farms. Scalability has a post pointing out some issues related to a trademark for HMMer granted to Eddy back in early April. Currently, there several open source "flavors" or "forked off" versions of HMMer, such as GPU-HMMer and mpiHMMer, that may have to be renamed or no longer distributed due to the stipulations in the trademark.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.